3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
13
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
12
Rectal Neoplasms
5
Urinary Bladder Neoplasms
4
Pancreatic Neoplasms
4
Neoplasms
4
Esophageal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
3
Recurrence
3
Ovarian Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Postoperative Complications
2
Pathologic Complete Response
2
Head and Neck Neoplasms
2
Breast Cancer Patients
2
Surgery
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Salivary Gland Neoplasms
1
Radiation Injuries
1
QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Neoadjuvant Chemotherapy
1
Interventions
Blood Specimen Collection
7
Drug Therapy
6
Surveys and Questionnaires
5
Radiotherapy
5
Radiosurgery
5
Docetaxel
5
Therapeutics
4
Specimen Handling
4
Immunotherapy
4
Hepatectomy
4
exemestane
3
enzalutamide
3
apalutamide
3
Trastuzumab
3
Hematologic Tests
3
Data Collection
3
Biopsy
3
Biological Assay
3
Anastrozole
3
Abiraterone Acetate
3
trastuzumab deruxtecan
2
palbociclib
2
darolutamide
2
abiraterone
2
abemaciclib
2
Wearable Electronic Devices
2
Triptorelin Pamoate
2
Tamoxifen
2
Surgical Procedures, Operative
2
Radiotherapy, Intensity-Modulated
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Neoplasm Metastasis
×
Neoadjuvant Therapy
×
Clear all
NCT02251353
2020-02-21
IMET
Federation of Breast Diseases Societies
Unknown
300 enrolled